Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — H1 FY2023 Earnings Presentation
27 slides from Nath Bio-genes (india)'s earnings presentation, Oct 20, 2022
Slide 1: Nath Bio-Genes (I) Ltd. exchange filing letter
oe. Nath Bio-Genes (I) Ltd. , (CIN L01110MH1993PLC072842) 20th October 2022 The Manager-Listing The Manager-Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-40000 1 Mumbai-400051 BSE Code-537291
Slide 2: One Seed, Many Lives: H1FY23 Investor Presentation
One Seed, Many Lives Sustainable Value Creation H1FY23 Investor Presentation Q1FY23 Investor Presentation
Slide 3: Disclaimer
Disclaimer Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual
Slide 4: Strategy for Sustainable Value Creation
Strategy for Sustainable Value Creation 1 TAILOR MADE 2 SUPERIOR 3 Strong R&D 4 INVESTMENT PRODUCTS PRODUCT Focus GRADE . PERFORMANCE BALANCE SHEET Customized products to High Yield and Strong Bio tech integrated Zero Long Term Debt address key farmer Pest and Disease innovation requirements Resista
Slide 5: Competitive Positioning in a Tough Sector
Competitive Positioning in a Tough Sector Focus Area Winning Strategies Product Selection • Focus on Cotton, Vegetables, • Build a dream product basket Fodder Bajra with superior and diversified products • Empower Stakeholders; Build long-term, loyal, symbiotic • Build Unapparelled Supply relationsh
Slide 6: What our Business Delivered in Last 5 Years
What our Business Delivered in Last 5 Years Revenue Growth (INR Cr) Average Selling Price (Rs) is Increasing 279 CAGR 10.4% 982 192 480 211 128 FY18 FY22 FY18 FY22 Field Crops Vegetables 5
Slide 7: Tailor Made Products
Tailor Made Products Understand key farmer requirements based on deep market research 1 Develop products to suits various agro climatic conditions 2 Focus on disease and pest resistance which automatically 3 results in higher yield 4 Stringent multistage trials before commercial development
Slide 8: Our Success Stories
a a © a“ - ©} Our Success Stories
Slide 9: Sanket – #1
Sanket – #1 Market Need: • High level of resistance to sucking pest ✓ Only Bt-Cotton hybrid in the Market • Yield losses ✓ High customer retention ✓ Recognized by Indian Ministry of Agriculture for its consistent performance through repeated All India What our R&D Produced: Coordinated Trials ✓ Expe
Slide 10: Testimonials: Sanket
Testimonials: “Sanket” Farmers on “Sanket” “खर्च कम वाला कॉटन कीड़े कण्ट्रोल में और खर्ाच भी कम ” “कीड़ा कम दवा कम और कपास ज्यादा ” 9
Slide 11: Super 27 - Deep-Rooting into Bajra
Super 27- Deep-Rooting into Bajra Market Need • High Yielding dual Purpose Hybrids • Crop window exploitation Our R&D efforts ✓ Product is seeing strong traction ✓ Addressable market of 3000 tons • High level of blast tolerance ✓ NBIL is expected to gain 50% market share in next • High biomass two y
Slide 12: Testimonials: Super 27
Testimonials: “Super 27” Farmers on “Super 27” “इतने बड़े ससट्टे वाला बiजरा मैंने कभी दे खा नह ीं था। ससट्टा बहुत मजबत ू है और दाना भर भर के है ” “पपछले साल मुझे सुपर 27 के उत्पाद भेजते वक्त 100 रूपया प्रतत कक्वींटल ज्यादा समले, इनके दानों का साइज और रीं ग दे सी टाइप है ” “डबल धमाके वाला बाजरा है - स
Slide 13: Akhand - Best Performing
Akhand- Best Performing Market Need • Very deep red colour fruits with better shelf life • Virus resistant hybrid • Higher Yield ✓ Strong demand seen in the market - Zero inventory left Our R&D Efforts ✓ Addressable market size - Rs 150cr • Shift from conventional breeding to Biotech- ✓ NBIL is expe
Slide 14: Testimonials: Akhand
Testimonials: “Akhand” Farmers on “ Akhand ” “ठोस और मजबूत फल, दरू भेजने के सलए जबरदस्त हैं! नुक्सान भी कम हैं” “लाल और टे स्ट फल, एक समान साइज हैं” “एक जैसा फल और जबरदस्त नफा होता हैं” 13
Slide 15: Focussed on R&D
Focussed on R&D • Well Invested, DSIR • Produce Genetically Pure and Premium recognized R&D Innovation Quality Seeds Centers • Prioritise Disease and Pest resistance • Cold storage facilities, breeding warehouses, and conditioning godowns having a capacity of 20,000MT 02 03 • R&D Team of • Large and
Slide 16: Focussed on Shareholder Value Creation
Focussed on Shareholder Value Creation Growing Business Product Excellence Strong Positions in important crops Innovation and solution that drive productivity and create value for farmers Differentiated Customer Experience Margin Expansion Expanding market reach through new Growing EBITDA margins th
Slide 17: H1FY23 Performance
H1FY23 PERFORMANCE 16
Slide 18: Key Operating and Financial Highlights
Key Operating and Financial Highlights o Non - cotton, non - paddy portfolio contribution at 41% to revenues; volume growth of 18% in H1 o Cotton and Paddy portfolio contribution at 59% to revenues Operating Performance o Vegetables and Bajra segments continue to deliver strong growth o Revenue in H
Slide 19: Segmental Revenue Contribution
Segmental Revenue Contribution H1FY22 Revenue H1FY23 Revenue INR 2,295Mn INR 2,310 Mn Others, 29% Cotton, 36% Cotton, 37% Others, 41% Paddy, 23% Paddy, 34% Cotton Paddy Others Cotton Paddy Others • include: Jowar, Bajra, Maize, Mustard, Wheat
Slide 20: Segment wise Operating Performance
Segment wise Operating Performance Products Metric H1FY23 H1FY22 YOY Growth FY22 Cotton Packets in lakhs 11.17 11.71 -4.6% 11.90 Paddy Quintals 59,261 40,730 45.5% 59,176 Other Crops (Bajra, Quintals 18,300 20,218 -9.5% 29,963 Maize) Vegetables Quintals 1,210 469 158.0% 2929 19
Slide 21: Income Statement
Income Statement Particulars (INR Mn) Q2FY23 Q2FY22 % Change (YoY) H1FY23 H1FY22 % Change (YoY) Total Revenue 217 149 45.6% 2,310 2,295 0.7% Gross Profit 168 125 34.4% 1,227 1,153 6.4% Gross Margin (%) 77.3% 83.9% 53.1% 50.2% EBITDA 48 44 9.1% 392 525 -25.3% EBITDA Margin (%) 21.9% 29.8% 17.0% 22.9%
Slide 22: Appendix
APPENDIX
Slide 23: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet Net Debt (INR Mn) Net Worth (INR Mn) 6,133 5,576 5,420 888 5,076 4,692 679 659 576 3,033 478 363 207 1,071 1,213 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 -121 EBITDA Margin (%) PAT Margin (%) 18% 18% 21% 22% 17% 1
Slide 24: Visionary Leadership; Attracting the Best Talent
Visionary Leadership; Attracting the Best Talent Mr. N Mr. Satish Nath Promoters are committed to sustainable Kagliwal Kagliwal MD growth and are working towards making Nath one Chairman of the best seeds company globally. Leadership Team Research & Product Development Nath leadership team shares th
Slide 25: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY22 FY21 FY20 Total Revenue 2,783 3076 2799 Gross Profit 1,544 1715 1536 Gross Margin (%) 56% 56% 55% EBITDA 373 667 547 EBITDA Margin (%) 13% 22% 20% Depreciation 31 28 14 Finance Cost 106 88 65 PBT (before exceptional)
Slide 26: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn)FY FY22 FY21 FY20 Liabilities FY22 FY21 FY20 Fixed Assets 2,449 2,469 2,460 Share Capital 190 190 190 Financial Assets 51 53 52 Reserves & Surplus 5,230 5,943 5,386 Other Non-current Assets 218 134 15 Long-Term Borrowings 7 7 3 Inventories 2,203 2,263 2,043 Lo
Slide 27: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja Monali Jain sheetal@GoIndiaadvisors.com monali@GoIndiaadvisors.com M:+91 97693 64166 M:+917597304020 26
Nath Bio-Genes (India) — H1 FY2023 Earnings Presentation on 6ix